These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6532543)

  • 1. Resistance to inactivating bacterial enzymes of different cephalosporins and in vitro activity.
    Ravizzola G; Manca N; Turano A
    Chemioterapia; 1984 Aug; 3(4):242-5. PubMed ID: 6532543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of selected antibiotics against anaerobes.
    Wexler HM; Finegold SM
    Clin Ther; 1987; 10 Suppl A():12-8. PubMed ID: 3690606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
    Marina M; Ivanova M; Kantardjiev T
    Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 6. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro sensitivity of strict anaerobic Gram-negative bacilli to thienamycin NF and various cephalosporins].
    Dubreuil L; Devos J; Romond C
    Pathol Biol (Paris); 1984 May; 32(5):429-32. PubMed ID: 6739150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefoxitin: its role in the therapy of anaerobic infections].
    Carvalho A; Fonseca C; Falcão F; Ceia F
    Acta Med Port; 1993 Oct; 6(10):467-71. PubMed ID: 8285118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
    Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
    Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of anaerobic bacteria to BAY v 3522.
    Nord CE; Rylander M; Norrby SR
    Antimicrob Agents Chemother; 1991 Mar; 35(3):594-9. PubMed ID: 2039213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
    Piccolomini R; Di Sipio L; Ravagnan G
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and susceptibility to antimicrobial agents of strictly anaerobic bacteria isolated from hospitalized patients].
    Kot K; Rokosz A; Sawicka-Grzelak A; łuczak M
    Med Dosw Mikrobiol; 2002; 54(3):233-41. PubMed ID: 12632658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of antimicrobial susceptibilities of clinically isolated anaerobic bacteria by E-test, ATB-ANA and agar dilution.
    Koru O; Ozyurt M
    Anaerobe; 2008 Jun; 14(3):161-5. PubMed ID: 18424192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.